What is the recommended community‑acquired pneumonia (CAP) treatment protocol based on severity assessment using CURB‑65 (confusion, urea, respiratory rate, blood pressure, age ≥ 65) or Pneumonia Severity Index (PSI), including outpatient low‑risk, outpatient with comorbidities, inpatient non‑ICU, and ICU regimens?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Community-Acquired Pneumonia Treatment Protocol

Use CURB-65 as your primary severity assessment tool to guide site-of-care decisions for all adult CAP patients, with scores 0-1 treated outpatient, score 2 requiring clinical judgment for possible hospitalization, and scores ≥3 mandating hospital admission with immediate ICU evaluation using IDSA/ATS severe CAP criteria. 1, 2

Initial Severity Assessment with CURB-65

CURB-65 assigns one point for each of the following criteria 1, 2:

  • Confusion (new-onset disorientation to person, place, or time)
  • Urea >19 mg/dL (or BUN >20 mg/dL, or 7 mmol/L)
  • Respiratory rate ≥30 breaths/minute
  • Blood pressure: systolic <90 mmHg or diastolic ≤60 mmHg
  • Age ≥65 years

Mortality Risk by Score 1, 2, 3:

  • Score 0: 0.7% mortality
  • Score 1: 2.1% mortality
  • Score 2: 9.2% mortality
  • Score 3: 14.5% mortality
  • Score 4: 40% mortality
  • Score 5: 57% mortality

Treatment Protocol by Risk Category

Low-Risk Outpatient (CURB-65 Score 0-1)

For previously healthy adults without comorbidities, use monotherapy 3:

  • Amoxicillin 1g three times daily, OR
  • Doxycycline 100mg twice daily

For adults with comorbidities (chronic heart/lung/liver/renal disease, diabetes, alcoholism, malignancy, asplenia), use combination therapy 3:

  • Amoxicillin-clavulanate PLUS macrolide (azithromycin or clarithromycin), OR
  • Cephalosporin (cefuroxime or cefpodoxime) PLUS macrolide

Expect clinical improvement within 3 days; patients must contact their physician if no improvement occurs 3.

Intermediate-Risk (CURB-65 Score 2)

This score carries 9.2% mortality and requires hospitalization or intensive in-home health services where available. 1, 2 Clinical judgment becomes critical at this threshold 3.

Factors that mandate admission despite score 2 2, 3:

  • Inability to maintain oral intake
  • Homelessness or lack of social support
  • Active substance abuse or severe psychiatric illness
  • Cognitive impairment affecting self-care
  • Failure of prior outpatient antibiotic therapy
  • Acute exacerbation of underlying comorbidities (COPD, heart failure)
  • Prior splenectomy

High-Risk Inpatient Non-ICU (CURB-65 Score ≥3 without ICU criteria)

All patients with CURB-65 ≥3 require hospital admission and immediate evaluation for ICU placement. 1, 2 However, CURB-65 alone performs poorly for ICU triage decisions (sensitivity only 78.4%) 2, so you must apply IDSA/ATS severe CAP criteria.

ICU Admission Criteria (IDSA/ATS Severe CAP)

Direct ICU admission is mandatory for patients meeting either major criterion 1, 2:

Major Criteria (any one requires ICU):

  • Septic shock requiring vasopressors
  • Acute respiratory failure requiring intubation and mechanical ventilation

Minor Criteria (≥3 require ICU or high-level monitoring unit) 1, 2:

  • Respiratory rate ≥30 breaths/minute
  • PaO₂/FiO₂ ratio ≤250
  • Multilobar infiltrates on chest imaging
  • Confusion/disorientation
  • Blood urea nitrogen ≥20 mg/dL
  • Leukopenia (WBC <4,000 cells/mm³) from infection
  • Thrombocytopenia (platelets <100,000/mm³)
  • Hypothermia (core temperature <36°C)
  • Hypotension requiring aggressive fluid resuscitation

Delayed ICU transfer (ward→ICU) is associated with significantly higher mortality, so evaluate ICU criteria immediately upon admission for all CURB-65 ≥3 patients. 1, 2

Alternative: Pneumonia Severity Index (PSI)

The PSI incorporates 20 variables and provides more granular risk stratification but is complex for emergency settings 1, 4. Use PSI when CURB-65 score is borderline (score 2) and you need additional detail to refine disposition decisions. 2

PSI Risk Classes 1, 4:

  • Class I-II (mortality ≤0.7%): Outpatient treatment
  • Class III (mortality 0.9-2.8%): Observation unit or short hospitalization
  • Class IV (mortality 8%): Hospitalization required
  • Class V (mortality 35%): Hospitalization required, high ICU risk

The PSI classifies slightly more patients as low-risk compared to CURB-65, but recent evidence shows CURB-65 is associated with lower 30-day mortality (8.6% vs 9.7%) and is more user-friendly. 1, 5

Critical Pitfalls to Avoid

Young patients (<65 years) with severe respiratory failure: CURB-65 may dangerously underestimate severity because age is heavily weighted; a 30-year-old with severe hypoxemia requiring high-flow oxygen scores only 0-2 points despite critical illness. 2, 3 Always assess oxygenation and work of breathing independently.

Elderly patients with stable comorbidities: A healthy 70-year-old with isolated tachypnea may score 2 points (age + respiratory rate) without true severe illness. 1, 2 Consider PSI or clinical gestalt in this scenario.

COPD patients: These patients have higher mechanical ventilation rates and ICU mortality when admitted with CAP, yet COPD is not captured in CURB-65 scoring. 1 Maintain lower threshold for admission.

For ICU decisions, never rely on CURB-65 alone—it has poor sensitivity for predicting need for critical care interventions. 2, 6 Always apply the IDSA/ATS severe CAP criteria systematically.

Simplified Alternative: CRB-65

When laboratory testing is unavailable (primary care office, resource-limited settings), use CRB-65, which omits the urea measurement and scores 0-4 points. 1, 2, 3 The same thresholds apply: 0-1 for outpatient, ≥2 for hospitalization consideration.

References

Related Questions

What is the best approach to manage a patient with pneumonia who has a high risk of mortality based on the CURB-65 (Confusion, Urea, Respiratory rate, Blood pressure, 65 years of age) criteria and Pneumonia Severity Index (PSI) score?
What is the recommended management and antibiotic regimen for community‑acquired pneumonia, including severity assessment (CURB‑65 or Pneumonia Severity Index), outpatient versus inpatient treatment, and specific choices for patients with recent antibiotic use, comorbidities, β‑lactam allergy, or risk factors for MRSA or Pseudomonas?
How should I assess severity and select empiric antibiotic therapy for an otherwise healthy adult with community‑acquired pneumonia (CAP) and a CURB‑65 score of 0‑1?
What is the management approach for pneumonia based on the Community-Acquired Pneumonia (CAP) severity assessment tool, CURB (Confusion, Urea, Respiratory rate, Blood pressure) 65 score?
How should I manage an otherwise healthy adult with community‑acquired pneumonia who meets outpatient criteria (CURB‑65 (Confusion, Urea, Respiratory rate, Blood pressure, age ≥ 65) score 0‑1, no significant comorbidities, stable vital signs, able to take oral medication)?
What is the recommended first‑line management for adult insomnia, including behavioral interventions (sleep hygiene, cognitive‑behavioral therapy for insomnia) and appropriate short‑term pharmacologic options?
I have an elevated thyroid‑stimulating hormone (TSH); what does this indicate and how should it be evaluated and treated?
Which magnetic resonance imaging protocol should be ordered for a suspected patellar tendon injury?
For a patient with asymptomatic bacteriuria due to ESBL‑producing Enterobacter cloacae that is trimethoprim‑sulfamethoxazole‑susceptible, no sulfa allergy, normal renal function, and no G6PD deficiency, should TMP‑SMX be used as peri‑operative prophylaxis before laser lithotripsy?
When should the first follow‑up appointment be scheduled after initiating antihypertensive medication?
Interpret this CBC with differential: WBC 17.3 ×10⁹/L (neutrophils 73.5%, absolute neutrophils 12.8 ×10⁹/L), immature granulocytes 1.8% (0.3 ×10⁹/L), lymphocytes 8.5% (1.5 ×10⁹/L), monocytes 9.2% (1.6 ×10⁹/L), eosinophils 6.1% (1.1 ×10⁹/L), basophils 0.9% (0.2 ×10⁹/L), nucleated red blood cells 1.7% (0.3 ×10⁹/L); RBC 2.90 ×10¹²/L, hemoglobin 8.1 g/dL, hematocrit 26.3%, MCV 90.7 fL, MCH 27.9 pg, MCHC 30.8 g/dL, RDW 18.6%, platelets 233 ×10⁹/L, MPV 9.4 fL.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.